Clinical Trials Sponsored by FzioMed

Total 148 results

FzioMed

Completed

Confirmatory Clinical Study of Oxiplex

Herniated Lumbar Disk

United States
Abiomed Inc.

Not yet recruiting

Abiomed Impella RT-DAQ - Observational Study

Cardiogenic Shock
Abiomed Inc.

Recruiting

The RECOVER IV Trial (RECOVER IV)

Cardiogenic Shock | ST-segment Elevation Myocardial Infarction (STEMI)

United States, Germany
Abiomed Inc.

Recruiting

Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function (PROTECT IV)

Coronary Artery Disease | Left Ventricular Dysfunction

United States, Switzerland, Germany, Canada, Italy, Netherlands, United Kingdom
Abiomed Inc.

Recruiting

SVC Occlusion in Subjects With Acute Decompensated Heart Failure (VENUS-HF)

Heart Diseases | Acute Decompensated Heart Failure | Congestive Heart Failure | Acute Heart Failure

United States
Abiomed Inc.

Active, not recruiting

Impella ECP Early Feasibility Study (ECP EFS)

High-risk Percutaneous Coronary Intervention

United States
Triomed AB

Completed

A Performance Analysis of the Peritoneal Ultrafiltration (PUF) Achieved With the Carry Life® UF

Chronic Renal Failure

Sweden
Abiomed Inc.

Terminated

MINI-AMI: Minimizing Infarct Size With Impella 2.5 Following PCI for Acute Myocardial Infarction (MINI-AMI)

ST-elevation Myocardial Infarction
Abiomed Inc.

Completed

Door To Unloading With IMPELLA CP System in Acute Myocardial Infarction - Safety and Feasibility Study (DTU)

STEMI

United States
Abiomed Inc.

Terminated

Voyager I: Patient Discharge Using the AB5000 Portable Driver System

Acute Cardiac Dysfunction
Abiomed Inc.

Recruiting

V-A ECMO AUTO Mode Registry

Heart Failure

Germany
Abiomed Inc.

Suspended

Breethe Abiomed Recovery regisTry (BART) (BART)

Heart Failure | Cardiopulmonary Bypass | ARDS

United States
Abiomed Inc.

Enrolling by invitation

Impella ECP Study (ECP Study) and Impella ECP Continued Access Protocol

High-Risk Percutaneous Coronary Intervention

United States
Abiomed Inc.

Enrolling by invitation

IMpella-Protected cArdiaC Surgery Trial (IMPACT) (IMPACT)

Left Ventricular Dysfunction

United States
Abiomed Inc.

Active, not recruiting

The Smart Pump Study

Cardiac Output

United States
Triomed AB

Completed

A Feasibility Study of Peritoneal Ultrafiltration With a Wearable Device, CLS UF, That Adds a Glucose-salt Solution to the Intraperitoneal Fluid in the Device, in Order to Maintain a Stable Intraperitoneal Osmolarity and Thereby Enhance Ultrafiltration.

Ultrafiltration Failure

Sweden
Abiomed Inc.

Unknown

The Use of Impella RP Support System in Patients With Right Heart Failure

Right Heart Failure

United States
Abiomed Inc.

No longer available

AbioCor Implantable Replacement Heart

Severe Biventricular End Stage Heart Disease
Abiomed Inc.

Terminated

Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability (RECOVER II)

Acute Myocardial Infarction

United States
Abiomed Inc.

Completed

PROTECT I, A Prospective Feasibility Trial Investigating the Use of IMPELLA RECOVER LP 2.5 System in Patients Undergoing High Risk PCI (PROTECT I)

Patients Undergoing High Risk PCI.

United States, Netherlands
Abiomed Inc.

Completed

RECOVER I Impella RECOVER LP/LD 5.0 Support System Safety and Feasibility Study (RECOVER I)

Cardiac Surgery

United States
Abiomed Inc.

Recruiting

Impella Real-World Surveillance of Patients Using Sodium Bicarbonate

Cardiogenic Shock | High Risk PCI

United States
Abiomed Inc.

Recruiting

IMPACT EU Post-Market Clinical Follow-Up Study

Left Ventricular Dysfunction

Germany
Abiomed Inc.

Recruiting

Use of the Impella BTR™ in Patients With Heart Failure: An Early Feasibility Study (BTR EFS)

Heart Failure | Acute Decompensated Heart Failure

United States
Abiomed Inc.

Recruiting

Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial (DTU-STEMI)

ST Elevation (STEMI) Myocardial Infarction of Anterior Wall

United States, Italy, Canada, Germany, Switzerland, Netherlands
Abiomed Inc.

Active, not recruiting

SURPASS Impella 5.5 Study

Acute Decompensated Heart Failure | Cardiogenic Shock

United States
Abiomed Inc.

Completed

Restore EF Observational Study

Coronary Artery Disease | Angina, Stable | Unstable Angina | NSTEMI - Non-ST Segment Elevation MI

United States
Triomed AB

Completed

A Feasibility Study of Peritoneal Dialysis With CLS PD, Which Removes Toxins and Maintains a Stable Ultrafiltration by Continuously Regenerating a Recirculating Intraperitoneal Fluid, in Patients With End Stage Renal Disease, ESRD, With PD Therapy.

Peritoneal Dialysis

Sweden
Triomed AB

Terminated

A Clinical Study of the Safety and Efficacy of a Wearable Device (CLS UF) That Delivers Continuous Administration of Glucose to Recirculated Peritoneal Dialysis Fluid for the Purpose of Ultrafiltration in Patients With Congestive Heart Failure

Heart Failure | Cardio-Renal Syndrome

Germany
Abiomed Inc.

Unknown

Symphony: The Implantable Counter Pulsation Device (CPD) Safety and Feasibility Trial (Symphony)

Chronic Heart Failure

Canada
Abiomed Inc.

Terminated

Protect II, A Prospective, Multicenter Randomized Controlled Trial (PROTECT II)

Coronary Artery Disease

United States, Netherlands, Canada
Atlas Biomed

Terminated

Study of the Genome, Gut Metagenome and Diet of Patients With Incident Parkinson's Disease

Parkinson Disease | Genetic Predisposition

Russian Federation
Atlas Biomed

Completed

Study of the Genome, Gut Metagenome and Lifestyle of Patients With Incident Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2 | Genetic Predisposition | Metagenome

Russian Federation
Kiomed Pharma

Unknown

sAfety PerfoRmance chitOsan osteOarthritis ViscosupplEmentation (APROOVE)

Knee Osteoarthritis
Atlas Biomed

Withdrawn

Dietary Fibers Effect on the Gut Microbiota Composition

Inflammation | Metabolic Syndrome | Dyslipidemias | Cardiovascular Risk Factor | Microbiome

Russian Federation
Mainz Biomed

Not yet recruiting

Clinical Performance of the Mainz Biomed Colorectal Cancer Screening Test for Colorectal Cancer and Advanced Adenoma (reconAAsense)

Colorectal Neoplasms | Colorectal Cancer | Colorectal Adenoma | Colorectal Polyp
Kiomed Pharma

Recruiting

Long-term Safety and Performance of KiOmedine CM-Chitosan Supplementation in Advanced Symptomatic Knee Osteoarthritis (PIONEER)

Osteoarthritis, Knee

Belgium
Kiomed Pharma

Active, not recruiting

Evaluation of Performance and Safety of KIO015 in Face Skin Hydration Improvement (PLUM)

Skin Quality

France
AxioMed Spine Corporation

Unknown

Freedom Lumbar Disc in the Treatment of Lumbar Degenerative Disc Disease (FLD)

Degenerative Disc Disease (DDD)

United States, Germany
AxioMed Spine Corporation

Unknown

Freedom® Cervical Disc Use In The Treatment of Cervical Degenerative Disc Disease

Symptomatic Cervical Degenerative Disc Disease (DDD) From C3-C7

Germany, Switzerland
Matrix Biomed, Inc.

Recruiting

Treatment of Radiation and Cisplatin Induced Toxicities With Tempol

Mucositis | Nephrotoxicity | Ototoxicity

United States
IBSS Biomed S.A.

Active, not recruiting

Immunogenicity and Safety of Vaccine Against Tetanus and Diphtheria. (Clodivac)

Tetanus | Diphtheria

Poland
Prima BioMed Ltd

Completed

Ovarian Cancer Vaccine for Patients in Remission

Epithelial Ovarian Cancer

United States, Australia
Prima BioMed Ltd

Withdrawn

Cvac as Maintenance Treatment Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas

Pancreatic Carcinoma Stage I | Pancreatic Carcinoma Stage II
Niso Biomed S.R.L.

Unknown

Endofaster Test for Helicobacter Pylori Detection in Patients on Proton Pump Inhibitor Therapy

Helicobacter Infections

United Kingdom
Anaconda Biomed S.L.

Not yet recruiting

Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA5 Device (ATHENA)

Acute Ischemic Stroke From Large Vessel Occlusion
Anaconda Biomed S.L.

Completed

ANAIS Study to Confirm the Safety and Performance of the ANA 5F Advanced Neurovascular Access® (ANAIS)

Acute Ischemic Stroke

Spain
Anaconda Biomed S.L.

Terminated

Assessing Safety and Performance of the ANA Catheter System, Combined With a Stent Retriever in Acute Ischemic Stroke (SOLONDA)

Stroke, Ischemic

Spain
Prima BioMed Ltd

Terminated

Cvac as Maintenance Treatment in Patients With Epithelial Ovarian Cancer in Complete Remission Following First-line Chemotherapy or Second-line Treatment (CANVAS)

Epithelial Ovarian Cancer

United States, Australia
Matrix Biomed, Inc.

Available

Treatment of Metastatic Cancer in Terminally Diagnosed Patients

Metastatic Cancer

United States

3

Subscribe